As the founder and President of MAPS, Rick Doblin will present an exploration into the future of psychedelics, focusing on both drug policy reform and sponsoring cutting-edge psychedelic research. He will discuss the necessity of evidence-based drug policy reform and bipartisanship, as well as the potential for policy frameworks that prioritize public health, safety, and harm reduction. Lastly, Rick will share groundbreaking insights into the therapeutic investigations of psychedelic-assisted therapy for various mental health conditions, including post-traumatic stress disorder (PTSD).
Other Resources / Information
- Learn key insights into the challenges and opportunities surrounding the integration of psychedelic-assisted therapy into mainstream medicines.
- Learn the importance of evidence-based drug policy reform to facilitate the safe and responsible integration of psychedelics into society.
- Learn about the importance of bipartisanship in drug policy reform so we can move forward toward a collaborative and spiritualized humanity.
- Rick Doblin, Communications Officer, Multidisciplinary Association for Psychedelic Studies (MAPS)
Grace Cepe, Communications Officer, MAPS
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.